sales third thank At Good million, our currency sales our summarize year-over-year, conclude I’ll quarter product again point quarter by X more financial outlook. Joe. provide being third line our view. joining morning results were and Thanks, about XXXX XXX our $XXX you adjusted on and third trends call. Integer’s with details grew the with for XX% consistent preliminary our mostly our quarter October basis euro. drag, driven with results XXXX
up currency, Excluding acquisitions we and are year-over-year. X%
three third deteriorating $XX approximately have not deliveries our the reminder, performance been from a As and for commitments higher quarter primarily if would suppliers. million missed sales
third provided quarter and supplier sales are costs. by Our below the in an was volume direct by deliver million we effort lower wages, Manufacturing of $X million an adding $X last which adjusted adjusted manufacturing $XX guidance had million, Adjusted $XX X% year, the from and XXXX. increased that million, approximately higher income end $XX of of was million, the more in million freight reduced is The higher delays due compared sales high driven operating up EBITDA increase income July. with quarter to in slightly to to third X%. operating in labor quarter, the costs $X
cost fourth quarter benefit third the guidance. $X.XX XXXX. income year-to-date quarter levels. annualized net give quarter That net fourth delivered from $X.XX to color adjusted is the sold, align incentive following said, to and year diluted more to a third spend benefit savings adjusted lower be we from the includes and costs includes quarter SG&A the from we our higher on costs it similar typically the slide. with we to earnings of will expect than SG&A compensation highest on per down end-of-year share, SG&A quarter Though third saw some fourth of at of from in offset the I $XX adjusted updated quarter our the With as restructuring million, expense a second quarterly and services. an manufacturing As our higher goods income the in actions, the our quarter
higher due expenses adjusted dollar. debt than stronger than third of million outstanding our interest a by The partially decreased interest an rate last currency impacted benefit primarily income million higher more The to $X the XXXX, year U.S. net by in higher also quarter expense the offset interest increase to from Oscor to due by principal $X environment being the million acquisitions. the amount million $X increasing is of but third compared Aran and from the in quarter driven $XXX
approximately outcome the said, expect the XX% the rest increase Although year. long-term. fixed the and continue moves of view our to we the expense swap, is that subscribe rest an with therefore, floating to the through over the best market to interest of That we rate produces debt with through LIBOR interest
to quarter of XXXX, quarter effective a the compared of rate $X.XX Our third XX.X% year-over-year XX% was tax in the adjusted in of share. roughly creating headwind third XXXX per
in million operating of $XX the biggest XXXX first being the activities, XXXX, quarter The items generated year quarters, discrete third because $XX sequentially benefited rate an ship from the million quarter added effective delays. up quarter flow that with grown the project third with the in we million quarter rate adjusted We from third XX% through a not tax quarter. did total second In the being driver supplier of in the of we the has fourth cash single from rate XX.X% XX%. in Inventory and products three to $XX quarter. increase the
in fourth to quarter. inventory the expect reduce We
$XX of of organic as the inventory expect year-to-date the time and million in $XX following since Our between third free in growth. million for by million continue to increase of acquisition that at million We of still flow, XXXX. total the we investments we million the peaking quarter. Biomedical, reflects $XXX second of debt capabilities to quarter quarter and in balance $XX the decreased million it million capital spend of third CapEx the $XX cash expenditures end and net impact With capacity year-to-date spend in the our Aran $XX $XX
at the adjusted the down X.Xx end leverage quarter third the debt trailing was second Our from quarter. EBITDA, slightly of four-quarter
target our Although to the expect quarter the acquisition, X.Xx we are between X.Xx to in we improve XXXX to again and to in X.Xx of quarter our third still leverage leverage. range be fourth Aran of and temporarily X.Xx the due expect above
sales lines. product sales. Cardio Vascular of the to the quarter of the XX% XXXX strong XX% with compared quarter Trailing third transition four-quarter all first product reported sales Beginning of now will discussion line, in quarter XXXX. to with We and across third growth in up a were product line our grew our third
ultimately we that Heart to have the quarter. chain grew As discussed, double-digit pushed and previously markets. of out and supply caused we Structural continue environment sales face on demand a high-growth backlog to impact, Electrophysiology this challenging we in the strong be Despite
continued performance XX%. accelerate Cardio our have Vascular from quarter continue which sales Trailing fourth growth, seen and to strong strong also both acquisitions, year-over-year Aran Oscor growth. We and up sales the
the year. this expect continue We throughout momentum to
sales discussed. with In four-quarter Neuromodulation, Orthopedics Portable products Moving up plan sales delays our production. exit provide XX%, third we Advanced to our of in with driven our they quarter that X%. sales the our to includes X% need line, customers beginning our portable growth were acquisition. Medical from supplier the Trailing medical posted Surgical, quarter, our and This Oscor of Management by to impact products product neuromodulation grew as primarily of multi-year the and Cardiac transition growth as previously year-over-year the affected third sales Rhythm work the
generated growth low sales double-digit four-quarter also and Trailing was Surgical in roughly year-over-year. Advanced quarter. We third business Orthopedics the the in flat
nonmedical segment. with up the wrap we Electrochem, will Finally, discussion product our line
environmental, XX% energy lower sales delays. energy military quarter due driven XX% Third strong supplier and to could markets than recovering four-quarter continued the the market despite been driven sales demand grew they year-over-year, being across by have market. energy increased in the sales by Trailing
performance transition outlook XXXX. of to to the to with X in sales, last to Oscor now basis, are our for And acquisitions. billion, organic the be XX% sales forecasting Starting We to expect versus expectations X% to X% consistent updated year The October an sales update. billion compared the with noteworthy XXXX. million $X.XX year. will delay, we $X.XX we and range our considering grow XX% increase on sales our from full to includes an sales This Aran is of $XX
EBITDA additional adjusted million with due was higher freight million sales $XX approximately labor. shared, of lower direct volume costs updated and from million our previously adjusted by and As the income $X forecast and supplier to operating $XX from increased delays impacted wages, manufacturing
XXXX impacts, is With be EBITDA X% million between year-over-year to expect adjusted growth. to million, and $XXX which $XXX flat we these
between be million a reflecting be to $X.XX. income between operating of of growth $XXX adjusted is XXXX expected and $X.XX our a Adjusted decline EPS million, $XXX X% X%. expect to to We to
delayed outlook the of the as projected higher EPS latest which the our rate, be between adjusted XX% view mentioned adjusted interest is tax Our year. effective manufacturing includes earlier, costs, to for higher to impact sales, XX.X% and of expense
strong expect organically $XX $XX to reduce we cash to million used third $XX between the invest execute on As demand flow the as This cash supplier through inclusive have adjusted debt business expect continued inventory million flow the million to million free be impact to $XX million continue our expenditures $XXX of we quarter to also with now I outlook. $XXX growth. we we in shipments. from close, free to of operations to to as of $XX strategy, between million. we expect cash includes to is generate spend now of have $XX we by to investment between drive net flow our latest million. expect are million. estimate and our It EBITDA Most delayed outlook total and to the generate Consistent maintaining will We the still capital CapEx, made
our range you. with of to We our call X.Xx. and ratio Thank year expect will that, to With adjusted end X.Xx I to back Joe. to between the the X.Xx target within close leverage EBITDA, turn X.Xx